Business Daily Media

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

  • Written by ACN Newswire - Press Releases

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

SYDNEY, Oct 14, 2021 - (ACN Newswire) - Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program designed to keep the invention Australian owned - while rolling out treatment to the world.
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Prof Thomas Borody
- Topelia announces US$25 mil Series A

Read more //?#

SME Spending Signals Growing Confidence Among APAC Businesses: Instarem SME Spend Barometer

Inaugural report highlights spending behaviours among SMEs in Singapore, Australia, and Malaysia, revealing a strategic shift toward long-term gro...

Employment entitlements businesses need to know when hiring remote employees

In today's digitally connected world, companies are no longer limited by geographical boundaries when it comes to hiring. Tapping into overseas ta...

Remove the Guess Work in Location Planning

Planning where to open a new business location is a high-stakes decision. To help remove any guess work, Melbourne-headquartered GapMaps, a leader...

Employers and employees back Right to Disconnect but it’s complicated

Nearly three-quarters (74%) of Australian employers support the ‘Right to Disconnect’ legislation in Australia, according to a new survey by globa...

Financial headwinds continue to impact Australians as ASIC’s latest figures reveal more hardship ahead

WCT Advisory grows three-fold to handle increasing workload As the spiralling cost of living continues to wreak havoc on the average Australian...

Australia’s Spriggy Pocket Money App Dials Up Fastter To Launch Spriggy Mobile Plans

Fastter, an Australian first creative telecommunications studio that develops and manages virtual mobile networks for Australia’s largest brands, ha...